KidneyCure

About:

KidneyCure is a developing proprietary cell therapies aiming to prevent progression of Chronic Kidney Disease.

Website: https://www.kidneycure.com

Top Investors: Aurum Ventures MKI

Description:

KidneyCure Ltd. is developing proprietary cell therapies aiming to prevent progression of Chronic Kidney Disease. The scientific basis and motivation for KidneyCure’s approach was provided by a world-renowned authority in Nephrology Prof. Benjamin Dekel, through genuinely pioneering research carried in his laboratory at Sheba Medical Center in Israel, one of the world’s leading medical centers. KidneyCure’s unique 3D renal cell cluster technology is expected to significantly delay the need for dialysis and transplantation and give millions of patients an opportunity to live longer higher quality lives.

Total Funding Amount:

$4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tel Aviv, Tel Aviv, Israel

Founded Date:

2009-01-01

Contact Email:

info(AT)kidneycure.com

Founders:

Benjamin Dekel, Orit Harari-Steinberg

Number of Employees:

1-10

Last Funding Date:

2018-11-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai